Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
![]()
Higher Education
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
![]()
Drug Prices
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
![]()
Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
Prescription Drug Importation Fuels More Questions than Answers
![Prescription drugs]()
Drug Prices
Prescription Drug Importation Fuels More Questions than Answers
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
![]()
Drug Prices
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
President Trump’s 'Most Favored Nation' Executive Order Won’t Lower Drug Prices Immediately
![]()
Drug Prices
President Trump’s 'Most Favored Nation' Executive Order Won’t Lower Drug Prices Immediately
Analysis: U.S. Pays Substantially More than Australia for the Same Prescription Drugs
![]()
Drug Prices
Analysis: U.S. Pays Substantially More than Australia for the Same Prescription Drugs
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
![]()
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
In Pandemic, Pharma Attempts an Image Reset — But Americans Still Want Pricing Reform
![]()
Drug Prices
In Pandemic, Pharma Attempts an Image Reset — But Americans Still Want Pricing Reform
'Canary in a Coal Mine': Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs
![Pills at a pharmacy]()
Drug Prices
'Canary in a Coal Mine': Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs
'Buy American' Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
![]()
Drug Prices
'Buy American' Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
Explainer
A Letter to CMS on the Proposed Medicaid Rule
![Seema Verma]()
Drug Prices
A Letter to CMS on the Proposed Medicaid Rule
Executive Orders Unlikely to Lower Drug Prices
![]()
Drug Prices
Executive Orders Unlikely to Lower Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
![]()
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
Gilead Sets Two Separate Prices for its COVID-19 Drug in the United States, Charging More to Treat Most Americans
![]()
Drug Prices
Gilead Sets Two Separate Prices for its COVID-19 Drug in the United States, Charging More to Treat Most Americans
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
![]()
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic
Drug Prices
Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic
$761 million
COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain
![]()
Drug Prices
COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
![]()
Drug Prices
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Four Key Moments from Trump's State of the Union Address
![]()
Community Supervision
Four Key Moments from Trump's State of the Union Address
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Evidence-Based Policy
- The Opioid Epidemic
- Retirement Policy
- Policing
- Complex Care
- Drug Prices
- Higher Education
